1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automatic Control 19:716–723
2. Baguley BC, Ching LM (1997) Immunomodulatory actions of xanthenone anticancer agents. BioDrugs 8:119–127
3. Baguley B, Jameson M, Zhao L, Dunlop I, Kestell P (1998) Implications of the albumin binding properties of the anticancer drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA) to its clinical trial. Proc Aust Soc Clin Exp Pharmacol Toxicol 5:208a
4. Chabot GG, Bissery MC, Corbett TC, Rutkowski K, Baker LH (1989) Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. Cancer Chemother Pharmacol 24:15–22
5. Ching LM, Joseph WR, Crosier KE, Baguley BC (1994) Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Cancer Res 54:870–872